Ademi & O’Reilly, LLP is investigating Meet (Nasdaq: MEET) for possible breaches of fiduciary duty and other violations of the law in connection with the sale to NuCom.
Ademi & O’Reilly, LLP alleges Meet’s financial outlook is improving and yet shareholders will receive only $6.30 per fully diluted share representing an enterprise value of approximately $500 million. The merger agreement unreasonably limits competing bids for Meet by prohibiting solicitation of further bids, and imposing a termination penalty if Meet accepts a superior bid. Meet insiders will receive millions of dollars as part of change of control arrangements. We are investigating the conduct of Meet’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Meet.